Esther Edet Bassey

Esther Edet Bassey

Auto-generated profile, based on publicly available information

Esther Edet Bassey

BSc. Faculty of Basic Medical Sciences, University of Uyo, Uyo, Nigeria.; Directorate of Research, TORASIF

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2021 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
ACAna Carla dos Santos Costa
Ana Carla dos Santos Costa
Mohammad Mehedi HasanMohammad Mehedi Hasan
Mohammad Mehedi Hasan
EXEleni Xenophontos
Eleni Xenophontos
PMParvathy Mohanan
Parvathy Mohanan
EBEsther Edet Bassey
Esther Edet Bassey
MEMohammad Yasir Essar
Mohammad Yasir Essar

6 July 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
Mohammad Mehedi HasanMohammad Mehedi Hasan
Mohammad Mehedi Hasan
ACAna Carla dos Santos Costa
Ana Carla dos Santos Costa
EXEleni Xenophontos
Eleni Xenophontos
PMParvathy Mohanan
Parvathy Mohanan
EBEsther Edet Bassey
Esther Edet Bassey
MEMohammad Yasir Essar
Mohammad Yasir Essar
Click on the article title to read more.

24 January 2022 in International Journal of Mental Health and Addiction
Verified
Journal Article
Closed access
PDF file
EBEsther Edet Bassey
Esther Edet Bassey
AGAparna Gupta
Aparna Gupta
AKArushi Kapoor
Arushi Kapoor
ABArnav Bansal
Arnav Bansal

4 August 2025 in Brain and Behavior
Verified
Journal Article
Open access
OAOlobatoke Tunde Ayomide
Olobatoke Tunde Ayomide
VCVishal Chavda
Vishal Chavda
Bipin ChaurasiaBipin Chaurasia
Bipin Chaurasia
EBEsther Bassey
Esther Bassey
KDKanishk Dang
Kanishk Dang
NANazmin Ahmed
Nazmin Ahmed
Background: Stroke remains a leading cause of death and disability worldwide, with ischemic stroke accounting for the majority of cases. Advances in reperfusion therapies, including intravenous thrombolysis (IVT) and mechanical thrombectomy (MT), have significantly improved outcomes for acute ischemic stroke patients. However, reperfusion brain injury (RBI), a paradoxical consequence of recanalization, poses a major challenge, driven by oxidative stress, inflammation, and blood‐brain barrier disruption. This review critically examines emerging therapeutic strategies to mitigate RBI, focusing on pharmacological agents such as edaravone, NXY‐059, and tenecteplase, as well as procedural innovations in thrombectomy.Methods: This review employed a systematic search of databases such as PubMed, Cochrane Library, Embase, and Scopus using certain keywords. A comparative analysis of thrombolysis and thrombectomy was done, and emerging techniques and drugs mitigating reperfusion brain injury (RBI) were discussed.Results: Thrombolysis and thrombectomy highlight key differences in efficacy, safety, and patient selection criteria. While thrombectomy demonstrates superior outcomes in large vessel occlusions (LVOs), thrombolysis remains a cornerstone for early intervention where thrombectomy is inaccessible. Essential drugs like NXY‐059, edaravone, uric acid, N‐acetylcysteine, and others are changing the care of RBI after stroke. Newer thrombectomy techniques and technologies are also promising. However, the evident efficacy of these methods is still inconsistent in various patients. While thrombectomy and thrombolysis have the potential to cause post‐stroke cognitive decline, thrombectomy leads to better outcomes, but patient‐specific factors such as age, previous medical history, infarct volume, and others must be considered. Neurorehabilitation is essential for patient recovery from post‐stroke cognitive decline. Strategies such as the use of gas‐mediated therapies, pharmacological agents, stem cell therapies, antioxidant nanomedicines, and modulation of specific proteins like sirtuins are emerging treatment techniques and are promising to change the narration of RBI management and impact patient outcomes.Conclusion: The review underscores the need for precision medicine approaches, improved imaging for patient selection, and comprehensive longitudinal studies to optimize reperfusion strategies. Targeted interventions addressing oxidative damage and inflammation hold promise for reducing RBI and improving long‐term patient outcomes.

1 July 2021 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
ENEmmanuella Nzeribe
Emmanuella Nzeribe
UMUdofa Edidiong Michael
Udofa Edidiong Michael
SMShuaibu Saidu Musa
Shuaibu Saidu Musa
MMMirindi Batumike Marc
Mirindi Batumike Marc
SDSuccess David
Success David
DLDon Eliseo Lucero-Prisno
Don Eliseo Lucero-Prisno
COVID-19 being a public health emergency of international concern has emerged in most African countries including Niger. Niger, a landlocked country, is tasked with controlling the pandemic. However, of the big challenges the country faced is the fragility of healthcare system which posed limitations to the fight against the virus. The virus overwhelmed the fragile healthcare system which led to inaccessibility of quality healthcare to the citizens coupled with issues of flooding and economic recession that happened during the pandemic. The healthcare sectored has further been crippled by exposure and infection of the already insufficient healthcare workers. In addition to this, there was the burden of NTDs and other communicable and non-communicable diseases that subverted the country in the depths of difficulties. As per the predictions of World Bank, the poverty curve is likely to escalate due to the outrageous impacts of COVID-19. Adding on to this, the occurrence of natural disasters such as flooding has further stretched the country. It's no coincidence that the country would confront plethora of challenges amidst the second wave. Therefore, timely decision and necessary interventions are needed to strengthen the country's fight against the pandemic. However, this is only feasible when Nigerien government, international allies and other wealthy nations work closely to ensure that the challenges faced by the healthcare system are tackled.

24 June 2023 in World Neurosurgery
Verified
Journal Article
Closed access
BPBhavya Pahwa
Bhavya Pahwa
ATAnish Tayal
Anish Tayal
ASAnushruti Shukla
Anushruti Shukla
USUjjwal Soni
Ujjwal Soni
NGNamrata Gupta
Namrata Gupta
MSMayur Sharma
Mayur Sharma